5 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor MalignanciesNeoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, Thoracic Neoplasms, adenocarcinoma, breast disorder, breast neoplasm, cancer, carcinoma, epithelial neoplasm, lung cancer, lung disorder, lung neoplasm, neoplasm, neuroendocrine carcinoma, neuroendocrine neoplasm, primitive neuroectodermal tumor, respiratory system disorder, respiratory tract neoplasm, skin disorder, triple-negative breast carcinomaActive, not recruitingPhase 12026-08-26NCT06577987
Study of CHS-114 in Participants With Advanced Solid TumorsHead and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinomaActive, not recruitingPhase 12026-08-12NCT05635643
A First-in-Human Study of MEN2312 in Adults With Advanced Breast CancerAdvanced Breast CancerRecruitingPhase 12026-08-07NCT06638307
Study in Advanced Solid Tumor PatientsAdvanced Solid TumorRecruitingPhase 1 / Phase 22026-05-01NCT07300943
Less Frequent IV Dosing & Tumor Microenvironment (TME) Study of Nemvaleukin Alfa (ALKS 4230) Monotherapy and in Combination With Pembrolizumab (ARTISTRY-3)neoplasmActive, not recruitingPhase 1 / Phase 22024-06-07NCT04592653